| Entry |
|
|---|
| Name |
Ciladopa hydrochloride (USAN);
Tremerase (TN) |
|---|
| Formula |
C21H26N2O4. HCl
|
|---|
| Exact mass |
406.1659
|
|---|
| Mol weight |
406.9031
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01472 Dopamine agonist
|
|---|
| Efficacy |
Antiparkinsonian, Dopamine receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01472 Dopamine agonist
D03494 Ciladopa hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD1
D03494 Ciladopa hydrochloride (USAN)
DRD2
D03494 Ciladopa hydrochloride (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 28
1 C8y C 13.4400 -17.6400
2 C8y C 13.4400 -19.0400
3 C8x C 14.6300 -19.7400
4 C8x C 15.8900 -19.0400
5 C8y C 15.8900 -17.6400
6 C8x C 14.6300 -16.9400
7 O2a O 12.2500 -19.7400
8 C1a C 11.0600 -19.0400
9 C1c C 17.0800 -16.9400
10 C1b C 18.2700 -17.6400
11 N1y N 19.4600 -16.9400
12 O2a O 12.2500 -16.9400
13 C1a C 11.0600 -17.6400
14 O1a O 17.0800 -15.5400
15 C1x C 20.7200 -17.6400
16 C1x C 21.9800 -16.9400
17 N1y N 21.9800 -15.5400
18 C1x C 20.7900 -14.8400
19 C1x C 19.4600 -15.5400
20 C2y C 23.1700 -14.8400
21 C2x C 23.2400 -13.4400
22 C2x C 24.2900 -12.6700
23 C2x C 25.6900 -12.9500
24 C5x C 24.2900 -15.7500
25 C2x C 26.2500 -14.2800
26 C2x C 25.6200 -15.4700
27 O5x O 23.9400 -17.0800
28 X Cl 22.6800 -19.7400
BOND 29
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 7 8 1
9 5 9 1
10 9 10 1
11 10 11 1
12 1 12 1
13 12 13 1
14 9 14 1 #Down
15 11 15 1
16 15 16 1
17 16 17 1
18 17 18 1
19 18 19 1
20 11 19 1
21 17 20 1
22 22 23 2
23 20 24 1
24 23 25 1
25 21 22 1
26 24 26 1
27 20 21 2
28 25 26 2
29 24 27 2
|
|---|
